F Hirano1, A Kobayashi, Y Hirano
1Second Department of Internal Medicine, Asahikawa Medical College, Midorigaoka higashi 2-1, Asahikawa 078-8510, Japan. fhirano@asahikawa-med.ac.jp
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
This study explored how bile acids affect RANTES gene expression in liver cancer cells. Researchers found that certain types of bile acids increase RANTES protein and mRNA levels. They used experiments to show that this effect happens through NF-kappaB binding sites in the RANTES gene. More hydrophobic bile acids had stronger effects. CDCA, a specific bile acid, activated RANTES transcription in two cell lines. The team also found that NF-kappaB DNA-binding activity rose with bile acid treatment. These findings suggest bile acids may influence immune cell movement in liver diseases. The authors propose that this could explain RANTES roles in conditions like primary biliary cirrhosis.
Area of Science:
Background:
Prior research has shown that RANTES facilitates recruitment of immune cells to sites of inflammation. It was already known that bile acids influence immune responses in the liver. No prior work had resolved how bile acids might regulate RANTES gene expression in hepatoma cells. This gap motivated investigation into bile acid effects on RANTES transcription. Researchers had not yet determined whether NF-kappaB binding sites are involved in this regulation. The role of bile acid hydrophobicity in gene expression remained unclear. This study aimed to address these uncertainties. Understanding these mechanisms could clarify bile acid roles in liver inflammation.
Purpose Of The Study:
The researchers sought to determine how bile acids influence RANTES gene expression in hepatoma cells. They wanted to test if hydrophobic bile acids activate RANTES transcription. The specific problem was whether NF-kappaB binding sites mediate this effect. Motivation came from observing RANTES' role in immune cell migration. The study aimed to explore bile acid-induced RANTES expression in liver cells. Researchers focused on CDCA's effects on RANTES mRNA. They also wanted to assess how bile acid hydrophobicity affects gene regulation. This work could help explain bile acid roles in liver inflammation.
According to the authors, hydrophobic bile acids increase RANTES protein and mRNA levels via NF-kappaB binding sites.
The researchers propose that CDCA induces RANTES mRNA by activating NF-kappaB binding sites in the promoter region.
Electrophoretic mobility shift assays showed that bile acids increase NF-kappaB DNA-binding activity, suggesting a regulatory role.
The study found that more hydrophobic bile acids induce stronger RANTES gene expression in hepatoma cells.
Main Methods:
The study used human hepatoma cell lines for experiments. Researchers treated cells with hydrophobic bile acids. They measured RANTES protein levels after stimulation. Semiquantitative RT-PCR assessed mRNA expression. Electrophoretic mobility shift assays tested NF-kappaB activity. The team analyzed RANTES promoter regions for binding sites. They compared CDCA effects across different cell lines. Data collection included both protein and mRNA measurements.
Main Results:
Hydrophobic bile acids increased RANTES protein levels. CDCA induced RANTES mRNA expression in hepatoma cells. NF-kappaB binding activity rose with bile acid treatment. The RANTES promoter contained functional NF-kappaB sites. CDCA's effect was stronger in more hydrophobic bile acids. RT-PCR confirmed transcriptional activation of RANTES. Electrophoretic mobility shift assays supported NF-kappaB involvement. Results suggest bile acids regulate RANTES via NF-kappaB binding.
Conclusions:
The authors propose that bile acids induce RANTES gene expression. They suggest this occurs through NF-kappaB binding sites in the promoter. The study indicates bile acid hydrophobicity affects gene regulation. Researchers observed CDCA effects in two hepatoma cell lines. They propose that RANTES may mediate immune cell migration in liver disease. The findings suggest bile acids influence inflammatory processes in the liver. The team notes that this could explain RANTES roles in primary biliary cirrhosis. They emphasize the need for further studies on bile acid-immune interactions.
Semiquantitative RT-PCR revealed that CDCA increases RANTES mRNA levels in two hepatoma cell lines.
The authors propose that bile acids may contribute to immune cell migration in liver diseases like primary biliary cirrhosis.